The era of ‘one-size-fits-all’ treatment approaches is becoming history for pharmaceutical manufacturing with the future encountering a revolution in drug development through the introduction of additive manufacturing technologies. The innovative elements of this disruptive technology will affect all shareholders of the pharmaceutical chain from the industrial sector to the dispensing facilities and, ultimately, the patient end-user. In this review, we provide an overview of the most recent advances in dosage forms and devices using additive manufacturing technologies, along with the regulatory landscape framing the development and safety requirements for 3D-printed drug products before entering the pharmaceutical market.

“千篇一律”治疗方法的时代已成为制药业的历史，而未来将通过引入增材制造技术而在药物开发方面遇到一场革命。这种颠覆性技术的创新元素将影响从工业部门到配药设施的制药链的所有股东，并最终影响患者的最终用户。在这篇综述中，我们概述了使用增材制造技术的剂型和装置的最新进展，以及在进入制药市场之前对3D打印药物产品的开发和安全要求进行规范的法规环境。